11/18
09:00 am
cnsp
CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
High
Report
CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
11/15
09:21 am
cnsp
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
11/15
09:10 am
cnsp
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
Medium
Report
CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
11/4
09:34 am
cnsp
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment [Yahoo! Finance]
Medium
Report
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment [Yahoo! Finance]
11/4
09:15 am
cnsp
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
Low
Report
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
11/1
09:00 am
cnsp
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
Low
Report
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
10/23
03:10 pm
cnsp
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]
High
Report
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]
10/23
02:50 pm
cnsp
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
High
Report
CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
10/10
09:00 am
cnsp
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
Medium
Report
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
10/8
09:15 am
cnsp
CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
High
Report
CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
9/23
09:00 am
cnsp
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
Medium
Report
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
9/12
09:00 am
cnsp
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
Medium
Report
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
9/10
09:12 am
cnsp
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $0.50 price target on the stock.
Low
Report
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $0.50 price target on the stock.
9/4
09:19 am
cnsp
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]
Medium
Report
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]
9/4
09:05 am
cnsp
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
9/3
08:00 am
cnsp
IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
Low
Report
IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
8/27
09:10 am
cnsp
CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
Medium
Report
CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar